| National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications H Blencowe, S Cousens, MZ Oestergaard, D Chou, AB Moller, R Narwal, ... The Lancet 379 (9832), 2162-2172, 2012 | 6046 | 2012 |
| Born too soon: the global epidemiology of 15 million preterm births H Blencowe, S Cousens, D Chou, M Oestergaard, L Say, AB Moller, ... Reproductive health 10 (1), 1-14, 2013 | 2679 | 2013 |
| Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities MZ Oestergaard, M Inoue, S Yoshida, WR Mahanani, FM Gore, ... PLoS Med 8 (8), e1001080, 2011 | 631 | 2011 |
| Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma Journal of Clinical Oncology, 2017 | 420* | 2017 |
| Cancer genetics of epigenetic genes A Miremadi, MZ Oestergaard, PDP Pharoah, C Caldas Human molecular genetics 16 (R1), R28-R49, 2007 | 328 | 2007 |
| Newborn survival: a multi-country analysis of a decade of change JE Lawn, MV Kinney, RE Black, C Pitt, S Cousens, K Kerber, E Corbett, ... Health policy and planning 27 (suppl_3), iii6-iii28, 2012 | 276 | 2012 |
| Child mortality estimation: accelerated progress in reducing global child mortality, 1990–2010 K Hill, D You, M Inoue, MZ Oestergaard PLoS Med 9 (8), e1001303, 2012 | 168 | 2012 |
| A new method for deriving global estimates of maternal mortality JR Wilmoth, N Mizoguchi, MZ Oestergaard, L Say, CD Mathers, ... Statistics, Politics, and Policy 3 (2), 2012 | 115 | 2012 |
| Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL M Klanova, LH Sehn, I Bence-Bruckler, F Cavallo, J Jin, M Martelli, ... blood 133 (9), 919-926, 2019 | 111 | 2019 |
| The role of a bioresource research impact factor as an incentive to share human bioresources A Cambon-Thomsen, GA Thorisson, L Mabile Nature genetics 43 (6), 503, 2011 | 97 | 2011 |
| Common variants in mismatch repair genes and risk of colorectal cancer T Koessler, MZ Oestergaard, H Song, J Tyrer, B Perkins, AM Dunning, ... Gut 57 (8), 1097-1101, 2008 | 72 | 2008 |
| Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA … C Kurzeder, I Bover, F Marmé, J Rau, P Pautier, N Colombo, D Lorusso, ... Journal of Clinical Oncology 34 (21), 2516-2525, 2016 | 69 | 2016 |
| PD-L1 and tumor-associated macrophages in de novo DLBCL R McCord, CR Bolen, H Koeppen, EE Kadel, MZ Oestergaard, T Nielsen, ... Blood advances 3 (4), 531-540, 2019 | 65 | 2019 |
| Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy Clinical Cancer Research 25 (15), 4634-4643, 2019 | 61 | 2019 |
| Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential … V Jurinovic, V Passerini, MZ Oestergaard, A Knapp, K Mundt, S Araf, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 60 | 2019 |
| South African child deaths 1990–2011: have HIV services reversed the trend enough to meet Millennium Development Goal 4? KJ Kerber, JE Lawn, LF Johnson, M Mahy, RE Dorrington, H Phillips, ... AIDS (London, England) 27 (16), 2637, 2013 | 54 | 2013 |
| Interactions between genes involved in the antioxidant defence system and breast cancer risk MZ Oestergaard, J Tyrer, A Cebrian, M Shah, AM Dunning, BAJ Ponder, ... British journal of cancer 95 (4), 525-531, 2006 | 48 | 2006 |
| Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study CR Bolen, M Klanova, M Trneny, LH Sehn, J He, J Tong, JN Paulson, ... haematologica 105 (9), 2020 | 46 | 2020 |
| Prognostic impact of BCL2 and MYC expression and translocation in untreated DLBCL: results from the phase III GOYA study LH Sehn, MZ Oestergaard, M Trněný, A Bosi, M Egyed, A Illes, ... Hematological Oncology 35, 131-133, 2017 | 20 | 2017 |
| An idea whose time has come ?An African foresight observatory on genomics medicine and data-intensive global science C Dandara, C Adebamowo, J de Vries, E S Dove, E Fisher, R A Gibbs, ... Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2012 | 20 | 2012 |
